Hostname: page-component-7c8c6479df-8mjnm Total loading time: 0 Render date: 2024-03-28T15:59:12.588Z Has data issue: false hasContentIssue false

Current Psychotherapeutic Drugs. By F. M. Quitkin, D. C. Adams, C. L. Bowden, et al. Washington, DC: APA. 1998. 188 pp. $33.95 (pb). ISBN 0-98048-994-4

Published online by Cambridge University Press:  02 January 2018

David M. Taylor*
Affiliation:
Maudsley Hospital, Denmark Hill, London SE5 8AZ
Rights & Permissions [Opens in a new window]

Abstract

Type
Reviews
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 2000, The Royal College of Psychiatrists

There is, it seems, an endless supply of texts covering the science and practicalities of psychopharmacology. Largely they fall into two groups: standard reference texts dryly providing numerous data, but without pragmatic direction; and more considered texts which collate and synthesise data to provide more practical, clinically relevant guidance. Current Psychotherapeutic Drugs, however, falls somewhere between these extremes. Much of the information provided consists of pithy dosage recommendations similar to those found in any practical reference, such as the British National Formulary. But each chapter also includes a less prosaic, referenced introduction written, in the main, by a world-renowned expert. These two approaches combine fairly well to give a clinically relevant overview of psychopharmacological approaches to most areas of psychiatry. ?

The main shortcoming of this book is its parochialism: it is clearly intended for an American audience. Only drugs available in the USA are mentioned and only USA trade names are given. Only Food and Drug Administration dosage advice is provided. As a result, the book's usefulness to non-American readers is rather limited. This is perhaps exemplified by the absence of any mention of dothiepin, lofepramine, zuclopenthixol or amisulpride.

Current Psychotherapeutic Drugs contains a great deal of information, but ultimately fails as a reference text for use outside the USA. It is perhaps a worthwhile library text but I would not recommend it as a book to add to one's personal collection.

References

Washington, DC: APA. 1998. 188 pp. £33.95 (pb). ISBN 0-98048-994-4

Submit a response

eLetters

No eLetters have been published for this article.